Fabre Kramer Drug Patent Portfolio
Fabre Kramer owns 1 orange book drug protected by 1 US patent Given below is the list of Fabre Kramer's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7538116 | Treatment of sexual disorders | 02 Sep, 2025 | Active |
Latest Legal Activities on Fabre Kramer's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Fabre Kramer.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 14 Mar, 2024 | US7538116 |
| Letter from FDA or Dept of Agriculture re PTE application | 06 Feb, 2024 | US7538116 |
| Initial letter Re: PTE Application to regulating agency | 21 Nov, 2023 | US7538116 |
| Patent Term Extension Application under 35 USC 156 Filed | 16 Nov, 2023 | US7538116 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 25 Sep, 2020 | US7538116 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 05 Sep, 2019 | US7538116 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 26 May, 2009 | US7538116 |
|
Recordation of Patent Grant Mailed
Critical
| 26 May, 2009 | US7538116 |
|
Email Notification
Critical
| 07 May, 2009 | US7538116 |
|
Issue Notification Mailed
Critical
| 06 May, 2009 | US7538116 |
| Dispatch to FDC | 14 Apr, 2009 | US7538116 |
|
Application Is Considered Ready for Issue
Critical
| 14 Apr, 2009 | US7538116 |
|
Issue Fee Payment Received
Critical
| 13 Apr, 2009 | US7538116 |
|
Issue Fee Payment Verified
Critical
| 13 Apr, 2009 | US7538116 |
|
Mail Notice of Allowance
Critical
| 12 Jan, 2009 | US7538116 |
Fabre Kramer's Family Patents
Fabre Kramer Drug List
Given below is the complete list of Fabre Kramer's drugs and the patents protecting them.
1. Exxua
Exxua is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7538116 | Treatment of sexual disorders |
02 Sep, 2025
(8 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Exxua's drug page